Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- High-sensitivity troponin assays present opportunities, challenges for MI diagnosis
-
- Group supports patients with familial chylomicronemia syndrome James Falko, MD
- Jagmeet P. Singh, MD, DPhil, discusses challenges, rewards of clinical cardiology
- 2 decades of imaging
- Direct oral anticoagulants may increase risk for acute MI in patients with AF
- 30-minute office BP monitoring yields lower readings than routine procedures
- AHA: Insufficient evidence for benefit of fish oil supplements in general population
- AIDA: BVS linked to similar rate of TVF, higher rate of device thrombosis vs. metallic stent
- Major abnormalities on ECG tied to CVD risk in type 1 diabetes
-
- NSAIDs increase early risk for out-of-hospital cardiac arrest
- Patient discussion about herbal medicines, CVD link encouraged
- Weight fluctuation increases risk for death, CV events in patients with CAD
- Women less likely to be assessed, receive treatment for CVD than men
- CMS panel lukewarm on hospitalizations as outcome to determine coverage of HF technologies
- Serelaxin fails to meet primary endpoints of phase 3 study
- ABSORB III 2-year results suggest optimal techniques may be key
- Closed-loop stimulation pacing program reduces syncope in SPAIN trial
-
- CVD onset occurs earlier in people with higher BMI
- EBBINGHAUS: Evolocumab does not affect cognitive outcomes
- GIFT: Genetics-based dosing improves warfarin safety
- iFR noninferior to FFR for revascularization in patients with stable angina, ACS
- LEVO-CTS: Prophylactic levosimendan fails to improve outcomes in surgery population
- Marijuana use linked to higher risk for stroke, HF
- Patients with anomalous aortic origin of a coronary artery return to exercise after surgery
- Rise observed in hospital discharges of patients with Kawasaki disease
-
- SGLT2 inhibitors may lower risk for HF in patients with type 2 diabetes
- Trial Scorecard: AIDA
- Trial Scorecard: CARAT
- Trial Scorecard: CHEETAH
- Trial Scorecard: EBBINGHAUS
- Trial Scorecard: EXPERT CTO
- Trial Scorecard: RESET-HCM
- Trial Scorecard: SYMPATHY
-
- Trial Scorecard: VISION